Status:
COMPLETED
Effect of Domperidone on QT Interval in Premature Infants
Lead Sponsor:
Nantes University Hospital
Conditions:
Prematurity and Feeding Intolerance
Eligibility:
All Genders
10+ years
Phase:
PHASE2
Brief Summary
30 premature infants treated by domperidone upon decision of the attending neonatologist will have a daily recording of electrocardiogram for the first 7 seven days of treatment, and pharmacokinetics ...
Eligibility Criteria
Inclusion
- Gestational age less than 36 weeksPostnatal age greater than 10 days Treated / not treated by domperidone (case/control)Signed parental informed consent
Exclusion
- Severe cardiac arrhythmia Congenital heart disease (persistent ductus arteriosus excluded)Familial history of congenital long QT syndrome
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00238056
Last Update
January 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Nantes
Nantes, France, 44093